The heterogenization of tumour cells with tuberculin. I. The coupling of tuberculin to cell surfaces using con-A as ligand
- PMID: 6161888
- PMCID: PMC1458089
The heterogenization of tumour cells with tuberculin. I. The coupling of tuberculin to cell surfaces using con-A as ligand
Abstract
The introduction of an antigenic determinant strongly recognized by T cells on to a cell enhances the immune response to weak cellular antigens. Tuberculin (PPD) is a particularly suitable antigenic determinant for this purpose since it behaves in many ways as a 'T-cell hapten'. It has been found that direct chemical coupling of PPD to cell surfaces damages their antigenicity, but that this can be circumvented by coupling PPD to the lectin Concanavalin A and using this as the ligand for binding PPD to the cell. Techniques for preparing Con-A/PPD using little glutaraldehyde or SPDP as cross-linking agents are described.
Similar articles
-
Studies in the enhancement of tumour immunity by coupling strong antigens to tumour cells ('heterogenization of tumours'). Helper T cell clones against PPD help other T cells mount anti-tumour responses to PPD-coupled tumour cells.Immunology. 1984 Apr;51(4):755-63. Immunology. 1984. PMID: 6200428 Free PMC article.
-
The heterogenization of tumour cells with tuberculin. II. Studies of the antigenicity of tuberculin-heterogenized murine tumour cells in syngeneic BCG positive and BCG negative mice.Immunology. 1981 Feb;42(2):337-48. Immunology. 1981. PMID: 6161889 Free PMC article.
-
Induction of resistance to ascites tumor in mice with MFS-180 cells treated with glutaraldehyde, lipopolysaccharide, and concanavalin A.Cancer Res. 1981 Jul;41(7):2922-4. Cancer Res. 1981. PMID: 6788363
-
The killing of tumour cell targets coupled to tuberculin (PPD) by human and murine PPD-reactive T helper clones. I. PPD specificity of killing.Scand J Immunol. 1988 Mar;27(3):337-46. doi: 10.1111/j.1365-3083.1988.tb02355.x. Scand J Immunol. 1988. PMID: 2451275
-
Raising antibodies by coupling peptides to PPD and immunizing BCG-sensitized animals.Ciba Found Symp. 1986;119:25-57. doi: 10.1002/9780470513286.ch3. Ciba Found Symp. 1986. PMID: 3015516 Review.
Cited by
-
Purified protein derivative (PPD).Springer Semin Immunopathol. 1988;10(4):301-4. doi: 10.1007/BF02053842. Springer Semin Immunopathol. 1988. PMID: 3146815 No abstract available.
-
Immunoconjugates: applications in targeted drug delivery for cancer therapy.Pharm Res. 1987 Jun;4(3):181-8. doi: 10.1023/a:1016443725167. Pharm Res. 1987. PMID: 3334453 Review.
-
Studies in the enhancement of tumour immunity by coupling strong antigens to tumour cells ('heterogenization of tumours'). Helper T cell clones against PPD help other T cells mount anti-tumour responses to PPD-coupled tumour cells.Immunology. 1984 Apr;51(4):755-63. Immunology. 1984. PMID: 6200428 Free PMC article.
-
A preliminary trial of a novel form of active immunotherapy in squamous cell carcinoma of the lung.Br J Cancer. 1985 Mar;51(3):415-7. doi: 10.1038/bjc.1985.56. Br J Cancer. 1985. PMID: 3882114 Free PMC article. Clinical Trial. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources